Evidence map›Paper›PMID 42248873›Full record

ArticleNPJ Parkinson's disease2026

Neuroimaging evidence for a dopamine-independent association between motor cortex microstructure and Parkinson's disease severity.

Praveen Honhar, Sule Tinaz, Faranak Ebrahimian Sadabad, Mark Dias, Yanghong Yang, Shannan Henry, Ansel T Hillmer, Yasmin Zakiniaeiz, Rajiv Radhakrishnan, Robert A Comley and 7 more

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Praveen HonharDepartment of Biomedical Engineering, Yale School of Engineering and Applied Sciences, Yale University, New Haven, CT, USA. praveen.honhar@yale.edu.
Sule TinazDepartment of Neurology, Yale School of Medicine, New Haven, CT, USA.
Faranak Ebrahimian SadabadRadiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Mark DiasRadiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Yanghong YangRadiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Shannan HenryRadiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Ansel T HillmerDepartment of Biomedical Engineering, Yale School of Engineering and Applied Sciences, Yale University, New Haven, CT, USA.
Yasmin ZakiniaeizDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Rajiv RadhakrishnanDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Robert A ComleyAbbVie, North Chicago, IL, USA.
Xiaomeng ZhangAbbVie, North Chicago, IL, USA.
Bradley A HookerAbbVie, North Chicago, IL, USA.
Yu ZhangVA Palo Alto Health Care System, Palo Alto, CA, USA.
Sjoerd J FinnemaAbbVie, North Chicago, IL, USA.
Richard E CarsonDepartment of Biomedical Engineering, Yale School of Engineering and Applied Sciences, Yale University, New Haven, CT, USA.
Dustin Scheinost *Department of Biomedical Engineering, Yale School of Engineering and Applied Sciences, Yale University, New Haven, CT, USA.
David Matuskey *Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.

Funding

In vivo synaptic and dopamine transporter imaging in Parkinson's diseaseR01NS124819 · NINDS · YALE UNIVERSITY · PI DAVID A MATUSKEY · 2022 to 2026
$2.7M
Sex Differences in Alcohol Use Disorder Neurodegeneration using Multimodal PET and DTI NeuroimagingK01AA029706 · NIAAA · YALE UNIVERSITY · PI Yasmin Zakiniaeiz · 2022 to 2026
$881k
NIAAA NIH HHS K01 AA029706NIAAA NIH HHS K01AA029706NINDS NIH HHS 1R01NS124819NINDS NIH HHS R01 NS124819
6 · The paper itself

Abstract

We determined brain microstructure alterations in early-stage Parkinson's disease (PD) using diffusion tensor imaging and neurite orientation dispersion and density imaging (NODDI). Additionally, dopamine transporter (DAT) PET in PD was also performed to evaluate whether microstructural changes and dopaminergic losses within the brain contribute independently to PD motor severity. Mean diffusivity was significantly higher in PD in many mid-brain, nigrostriatal, sub-cortical, cortical and white matter regions. However, Viso (NODDI outcome for cerebrospinal-fluid volume fraction) in the motor cortices and parietal lobe were more strongly correlated (r ~ 0.5, p < 0.01) with PD motor severity. Most DAT PET and diffusion MRI measures were uncorrelated and stepwise multiple linear regression analysis determined a combination of DAT availability in the putamen and Viso in the precentral gyrus (motor cortex) as the best predictor of PD motor severity (55% variance explained); inclusion of Viso in precentral gyrus independently accounted for 11% variance in motor severity.

Identifiers

PMID42248873
PMCPMC13562690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.